AKLIEF

galderma canada inc🇨🇦 Health Canada

Approval Id: d87c004c8c6bcb4f
Drug Approval Canada Name: AKLIEF
Product Name: AKLIEF
Status: Marketed
Status Date: 2019-11-28
Original Market Date: 2019-11-28
Din: 02494175
Drug Class: Human
Dosage Form: Cream
Route Of Administration: Topical
Schedule: Prescription
Ahfs: 84:92.00
Atc Original: D10AD06 TRIFAROTENE
Atc Name: d 10 ad 06
Aig Number: 0161970001
Company Name: galderma canada inc
Company Address: SUITE 400, 55 Commerce Valley Drive West, Thornhill, Ontario, Canada, L3T 7V9

TRIFAROTENE

50 MCG / G

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

d87c004c8c6bcb4f

Type

Standard